Iterum Therapeutics Plc (ITRM)

05:16 AM

Will Iterum Therapeutics plc continue its uptrend2025 Investor Takeaways & Technical Buy Zone Confirmation - Newser

05:16 AM

Aug 13, 2025

Using data filters to optimize entry into Iterum Therapeutics plcMarket Risk Analysis & Smart Allocation Stock Reports - Newser

Aug 13, 2025

Aug 13, 2025

Iterum Therapeutics plc stock trend outlook and recovery path2025 Retail Activity & Technical Buy Zone Confirmations - Newser

Aug 13, 2025

Aug 13, 2025

Analyzing Iterum Therapeutics plc with multi timeframe chartsGap Down & Weekly Top Performers Watchlists - Newser

Aug 13, 2025

Aug 13, 2025

Chart based exit strategy for Iterum Therapeutics plc2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - Newser

Aug 13, 2025

Aug 13, 2025

Price momentum metrics for Iterum Therapeutics plc explainedJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - Newser

Aug 13, 2025

Aug 12, 2025

What’s next for Iterum Therapeutics plc stock priceLow Risk Stock Trade Opportunity Analysis - Newser

Aug 12, 2025

Aug 12, 2025

What institutional flow reveals about Iterum Therapeutics plcPattern Recognition Based Market Move Prediction - Newser

Aug 12, 2025

Aug 12, 2025

Using economic indicators to assess Iterum Therapeutics plc potentialStock Market Watch with Smart Filters - Newser

Aug 12, 2025

Aug 12, 2025

Advanced analytics toolkit walkthrough for Iterum Therapeutics plcSmart Trend Analysis With Buy Point Cues - Newser

Aug 12, 2025

Aug 12, 2025

Iterum therapeutics (ITRM) director Dunne buys $10,854 in shares - Investing.com

Aug 12, 2025

Aug 12, 2025

Iterum therapeutics (ITRM) director Dunne buys $10,854 in shares By Investing.com - Investing.com Australia

Aug 12, 2025

Aug 12, 2025

Iterum Therapeutics Director Dunne Buys 15,000 Shares at $0.72/Share on Aug 8. - AInvest

Aug 12, 2025

Aug 12, 2025

Real time pattern detection on Iterum Therapeutics plc stockSecure Buy Strategy Based on Risk Parameters - Newser

Aug 12, 2025

Aug 11, 2025

Why Iterum Therapeutics plc stock attracts strong analyst attentionLow Drawdown Picks with Weekly Updates - Newser

Aug 11, 2025

Aug 11, 2025

Developing predictive dashboards with Iterum Therapeutics plc dataFuture Growth Stock Forecasting Strategy - Newser

Aug 11, 2025

Aug 11, 2025

Will Iterum Therapeutics plc stock recover after recent dropReal Stock Picks With Setup Verification - Newser

Aug 11, 2025

Aug 10, 2025

Using Bollinger Bands to evaluate Iterum Therapeutics plcTrade Alert System with Volume Analysis - Newser

Aug 10, 2025

Aug 09, 2025

Iterum Therapeutics plc (NASDAQ:ITRM) Q2 2025 Earnings Call Transcript - MSN

Aug 09, 2025

Aug 09, 2025

Iterum Therapeutics (NASDAQ:ITRM) Downgraded by Wall Street Zen to “Sell” - Defense World

Aug 09, 2025

Aug 09, 2025

Iterum Therapeutics PLC (NASDAQ:ITRM) Short Interest Up 54.6% in July - Defense World

Aug 09, 2025

Aug 06, 2025

ITRM Reports Results - AOL.com

Aug 06, 2025

Aug 05, 2025

ITRM Reports Results - The Motley Fool

Aug 05, 2025

Aug 05, 2025

Iterum Therapeutics PLC reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 05, 2025

Aug 05, 2025

Iterum Therapeutics (ITRM) Financial Outlook for 2025 - GuruFocus

Aug 05, 2025

Aug 05, 2025

Iterum Therapeutics plc SEC 10-Q Report - TradingView

Aug 05, 2025

Aug 05, 2025

Iterum Therapeutics reports Q2 results, launches ORLYNVAH, extends cash runway to 2026. - AInvest

Aug 05, 2025

Aug 05, 2025

Iterum Therapeutics to Launch ORLYNVAH™ for Uncomplicated UTIs in August 2025, Reports Q2 Financial Results - Quiver Quantitative

Aug 05, 2025

Aug 05, 2025

Iterum Therapeutics reports Q2 revenue, cash runway into 2026, ORLYNVAH launch in August. - AInvest

Aug 05, 2025

Aug 05, 2025

Iterum Earnings Show $13M Cash as Revolutionary UTI Antibiotic ORLYNVAH Readies for Historic Launch - Stock Titan

Aug 05, 2025

Aug 05, 2025

Iterum Therapeutics (NASDAQ:ITRM) Shares Down 2.5% – Here’s Why - Defense World

Aug 05, 2025

Aug 05, 2025

Iterum Therapeutics Reports Second Quarter 2025 Financial Results - The Manila Times

Aug 05, 2025

Aug 04, 2025

Iterum Therapeutics Q2 Earnings Preview: Analysts Expect EPS of $-0.13 - AInvest

Aug 04, 2025

Aug 04, 2025

How to forecast Iterum Therapeutics plc trends using time seriesBull Market Summary and Recovery Outlook - Newser

Aug 04, 2025

Aug 04, 2025

What makes Iterum Therapeutics plc stock price move sharplyFree Accurate Technical Trend Reversal Picks - Newser

Aug 04, 2025

Aug 04, 2025

Exit strategy if you’re trapped in Iterum Therapeutics plcWealth Accumulation Outlook for Safe Investors - Newser

Aug 04, 2025

Aug 03, 2025

Is Iterum Therapeutics plc showing signs of accumulationHigh Yield Watchlist with Filtered Picks - Newser

Aug 03, 2025

Aug 03, 2025

How volatile is Iterum Therapeutics plc stock compared to the marketAchieve rapid financial growth with expert help - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the technical indicators suggesting about Iterum Therapeutics plcTremendous portfolio expansion - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the dividend policy of Iterum Therapeutics plc stockTremendous financial leverage - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Iterum Therapeutics plc a growth stock or a value stockBreakneck growth rates - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What drives Iterum Therapeutics plc stock priceAchieve consistent profits with smart trading - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the risk reward ratio of investing in Iterum Therapeutics plc stockGet timely advice on market trends - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Iterum Therapeutics plc stock higher in 2025Access high-yield investment alerts now - Jammu Links News

Aug 03, 2025